SCHEMBL8312242

SCHEMBL8312242

CCN1CCC(=O)c2cc3c(cc21)C(C)(C)CCC3(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 10/20 0.34
▸ RXRB P28702 2/20 0.32
▸ RXRG P48443 2/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ NOTUM Q6P988 1/20 0.32
▸ PRKD3 O94806 1/20 0.31
▸ PRKCG P05129 1/20 0.31
▸ PRKCB P05771 1/20 0.31
▸ PRKCA P17252 1/20 0.31
▸ PRKCH P24723 1/20 0.31
▸ PRKCI P41743 1/20 0.31
▸ PRKCE Q02156 1/20 0.31
▸ PRKCQ Q04759 1/20 0.31
▸ PRKCZ Q05513 1/20 0.31
▸ PRKCD Q05655 1/20 0.31
▸ PRKD1 Q15139 1/20 0.31
▸ OPRM1 P35372 1/20 0.30
▸ SIGMAR1 Q99720 1/20 0.30
▸ PRMT5 O14744 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8487393 0.75 NOTUM (0.34) HRH3NOTUMPRMT5WDR77
SCHEMBL8809982 0.73 HIF1A (0.41) RXRARXRBRXRGRARB
SCHEMBL24006333 0.72 KMT2A (0.33) HSP90AA1NOTUMPRMT5WDR77
SCHEMBL21886547 0.71 HSP90AA1 (0.32) HSP90AA1NOTUMPRMT5WDR77
SCHEMBL25882796 0.70 NOTUM (0.35) HRH3NOTUMPRKCD
SCHEMBL3009382 0.70 CASP3 (0.41) HRH3NOTUM
SCHEMBL8310387 0.69 RXRA (0.36) RXRARXRBRXRGRARB
SCHEMBL7624438 0.67 PBRM1 (0.44) RXRARXRBRXRGHRH3RARB
SCHEMBL29724092 0.67 MAPT (0.48) —
SCHEMBL28668402 0.67 MAPT (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933351-A1 Tricyclic retinoids, methods for their production and use LIGAND PHARMACEUTICALS INCORPORATED (US) 1999-08-04 — — EP disclosed
EP-0933350-A1 Tricyclic retinoids, methods for their production and use LIGAND PHARMACEUTICALS INCORPORATED (US) 1999-08-04 — — EP disclosed
US-5770382-A RETINOIC ACID AND RETINOID X RECEPTOR AGONISTS; TREATINGSKIN, EYE, BRAIN, AND CARDIOVASCULAR DISORDERS; CANCER LIGAND PHARMACEUTICALS, INC. (US) 1998-06-23 — — US disclosed
US-5770378-A A VITAMINE A METABOLITE, POTENT DRUGS TREATING SKIN DISEASES, CANCER, EYE DISEASES, CARDIOVASCULAR DISORDERS LIGAND PHARMACEUTICALS, INC. (US) 1998-06-23 — — US disclosed
US-5770383-A ACTIVATE RETINOID RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 1998-06-23 — — US disclosed
EP-0800504-A1 TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 — — EP disclosed
WO-1996020914-A1 TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-07-11 — — WO disclosed
Send feedback